ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Advanced Drug Delivery Reviews
Volume 58, Issue 15, 30 December 2006, Pages 1597-1621
2006 Supplementary Non-Thematic Collection
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (1007 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
Special issue
View Record in Scopus
 
doi:10.1016/j.addr.2006.09.019    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier B.V. All rights reserved.

Polymer genomics: An insight into pharmacology and toxicology of nanomedicinesstar, open

Alexander V. KabanovCorresponding Author Contact Information, maltese cross, a, E-mail The Corresponding Author

aCenter for Drug Delivery and Nanomedicine and Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Durham Research Center, 985830 Nebraska Medical Center, Omaha, Nebraska 68198-5830, USA

Received 13 September 2006; 
accepted 29 September 2006. 
Available online 6 October 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Synthetic polymers and nanomaterials display selective phenotypic effects in cells and in the body signal transduction mechanisms involved in inflammation, differentiation, proliferation, and apoptosis. When physically mixed or covalently conjugated with cytotoxic agents, bacterial DNA or antigens, polymers can drastically alter specific genetically controlled responses to these agents. These effects, in part, result from cooperative interactions of polymers and nanomaterials with plasma cell membranes and trafficking of polymers and nanomaterials to intracellular organelles. Cells and whole organism responses to these materials can be phenotype or genotype dependent. In selected cases, polymer agents can bypass limitations to biological responses imposed by the genotype, for example, phenotypic correction of immune response by polyelectrolytes. Overall, these effects are relatively benign as they do not result in cytotoxicity or major toxicities in the body. Collectively, however, these studies support the need for assessing pharmacogenomic effects of polymer materials to maximize clinical outcomes and understand the pharmacological and toxicological effects of polymer formulations of biological agents, i.e. polymer genomics.

Keywords: Artificial vaccines; DNA microarray; Drug resistance; Signal transduction; Phenotype

Article Outline

1. Introduction
2. Polymers and nanomaterials
3. Polymers and biomembranes: a pivotal biointerface
4. Toxicogenomics of nanomaterials
5. A synthetic polyelectrolyte-based vaccine
6. Activation of gene expression by polymers: a new gene delivery paradigm
7. Alteration of responses to drugs by polymers: a new drug delivery paradigm
8. Phenotype-selective sensitization of MDR tumors by Pluronic®
9. Alteration of genomic profiles in drug-selected cancer cells by pluronic®
10. Polymer genomics hypothesis and future studies
11. Conclusions
Acknowledgements
References






Advanced Drug Delivery Reviews
Volume 58, Issue 15, 30 December 2006, Pages 1597-1621
2006 Supplementary Non-Thematic Collection
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.